Cream Containing Sericin and Turmeric in Psoriasis Patients
NCT ID: NCT06482398
Last Updated: 2024-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2024-07-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Natural Gels for Treatment of Plaque Psoriasis
NCT02330237
Study of a New Dressing for Use With Topical Medications
NCT00234728
Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial
NCT04071106
Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Plaque Psoriasis
NCT05078567
A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris
NCT01268527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sericin extract and turmeric extract cream
Apply the sample 2 times a day for 8 weeks
Sericin extract and turmeric extract cream
Apply the sample 2 times a day for 8 weeks
Triamcinolone acetonide 1% cream
Apply the sample 2 times a day for 8 weeks
Triamcinolone acetonide 1% Cream
Apply the sample 2 times a day for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sericin extract and turmeric extract cream
Apply the sample 2 times a day for 8 weeks
Triamcinolone acetonide 1% Cream
Apply the sample 2 times a day for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with body surface area of psoriasis lesion less than 10, have psoriasis area and severity index less than 10 , and no lesion at face, hands,feet, and genital area
* No topical application on psoriasis lesion at least 2 weeks
* Willing to attend the study
Exclusion Criteria
* Allergic to sericin turmeric and steroid
* Other skin diseases
* Pregnancy and lactation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pornanong Aramwit, Pharm.D., Ph.D
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COA 0087/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.